// App-Quantinova.ai

SAT0192 : TRAJECTORIES OF LUPUS DISEASE ACTIVITY OVER TIME IN THE CLINICAL TRIAL SETTING REVEALED BY LATENT CLASS MIXED MODELS

Researchers

Presenter

  • J. Reynolds

Principal Investigators

  • J. Prattley

  • M. Lunt

  • N. Geifman

  • I. N. Bruce

Medical Centers

  • University of Birmingham, Institute of Inflammation and Ageing, Birmingham, UK

  • Sandwell and West Birmingham NHS Trust, Rheumatology, Birmingham, United Kingdom

  • School of Biological Sciences The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom

  • The University of Manchester, Division of Informatics, Imaging and Data Sciences, Manchester, United Kingdom

  • Manchester University NHS Foundation Trust, NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Prednisolone

  • Epratuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • Genzyme and Sanofi

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved